Home › Funds › FIRST AMERICAN TRUST, FSB › ABT

FIRST AMERICAN TRUST, FSB position in ABT

ABBOTT LABORATORIES · Health Care

FIRST AMERICAN TRUST, FSB reported holding 117,286 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$11.6M, representing 0.69% of its reported portfolio and ranking #38 among its reported holdings. FIRST AMERICAN TRUST, FSB has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)117.29K sh
Reported value held$11.59M
Portfolio Weight0.69%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How FIRST AMERICAN TRUST, FSB's ABT position evolved

FIRST AMERICAN TRUST, FSB first disclosed a stake in ABT in Q3 2023 at 99,123 shares (US$9.6M). The position peaked in Q1 2024 at 158,469 shares, worth US$18.0M. Across 13 filings, FIRST AMERICAN TRUST, FSB increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 117,286 shares valued at US$11.6M. Notable position changes include a 53% increase in Q4 2023 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 99.12K $9.60M New
Q4 2023 152.02K $16.73M Add
Q1 2024 158.47K $18.01M Add
Q2 2024 142.03K $14.76M Reduce
Q3 2024 112.26K $12.80M Reduce
Q4 2024 111.42K $12.60M Reduce
Q1 2025 113.22K $15.02M Add
Q2 2025 113.89K $15.49M Add
Q3 2025 114.28K $15.31M Hold
Q4 2025 113.25K $14.19M Reduce
Q1 2026 118.80K $12.20M Add
Q2 2026 116.99K $10.62M Reduce
Q3 2026 117.29K $11.59M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has FIRST AMERICAN TRUST, FSB held ABT?

FIRST AMERICAN TRUST, FSB has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is FIRST AMERICAN TRUST, FSB's current position in ABT?

As of Q3 2026, FIRST AMERICAN TRUST, FSB holds 117.29K shares of ABT (ABBOTT LABORATORIES), valued at $11.59M, representing 0.69% of its reported portfolio and ranking #38.

Has FIRST AMERICAN TRUST, FSB been buying or selling ABT?

In the latest 13F filing (Q3 2026), FIRST AMERICAN TRUST, FSB held unchanged its position in ABT. The position peaked in Q1 2024 at 158.47K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.